NOVOSEVEN 1 mg (50 KUI), poudre et solvant pour solution injectable

( ARTG ) NovoSeven RT is indicated for the control of bleeding and surgical prophylaxis in patients with: inhibitors to coagulation Factors VIII or IX; with congenital FVII deficiency; with Glanzmann's Thrombasthenia, who have antibodies to GPIIb-IIIa and/or HLA, and with past or present refractoriness to platelet transfusions.